GE HealthCare Technologies Inc. reaffirmed earnings guidance for the full year 2024. For the year, the company expected organic revenue growth of approximately 4% year-over-year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80.62 USD | -1.61% | -1.57% | +4.27% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.27% | 36.8B | |
+11.31% | 226B | |
+15.50% | 198B | |
+18.83% | 142B | |
+30.38% | 111B | |
+3.04% | 65.26B | |
+18.31% | 54.36B | |
+4.96% | 50.94B | |
+9.95% | 44.8B | |
+26.89% | 32.07B |
- Stock Market
- Equities
- GEHC Stock
- News GE HealthCare Technologies Inc.
- GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024